IndraLab

Statements

Hydroxychloroquine inhibits Antiphospholipid Syndrome. 2 / 2

1 | 1

reach

"Hydroxychloroquine therapy was initiated to prevent antiphospholipid antibody syndrome recurrence in a future pregnancy."

35287704

➶

ctd

No evidence text available

31092409

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine inhibits Antiphospholipid Syndrome. 2 / 2

INDRA sources:

Databases

Reading